Cannabis Testing Market Statistics, Trends, Segmentation Analys

  • Cannabis Testing Market 2021

    Astonishing growth in Cannabis Testing Market is expected to reach US$ 1,696.3 million by 2027, growing at an estimated CAGR of 14.4% over the forecast period

    The potency level and the potential of abuse of marijuana makes its use difficult even for medicinal purposes. After the declaration of marijuana as a “Schedule 1’ drug by the United States Drug Enforcement Administration, the transportation and handling of cannabis has been difficult. With the effort of many organizations who see the actual potential of recreated marijuana in medicinal applications, countries are now legalizing marijuana partially or fully. This has created a path of growth for many pharmaceutical companies in the region. For instance, The Aurora Cannabis, one of Canada’s largest licensed cannabis producers have recently signed a medical cannabis supply deal with Mexican pharmaceutical company Farmacias Magistrales. This exclusive strategic partnership makes the Mexican based pharmaceutical company country’s first cannabis import license following that development. Another example was when Medical Marijuana, Inc.'s distribution company, HempMeds decided that they would import the raw material, to start manufacturing medical marijuana products in Mexico and then export them to Europe, Canada, the United States and Latin America. Such factors is expected to propel the cannabis testing market over the next eight years.  

    Access Full Report Details and Order this Premium Report @


    Major Key Players:

    Some of the players operating in the Cannabis Testing Market are Anandia Labs, EVIO Labs, GREEN LEAF, PerkinElmer Inc., SGS Life Sciences, Steep Hill Labs, Inc., Thermo Fisher Scientific Inc. amongst others.

    Key Findings of the Report:

    In terms of revenue, Cannabis Testing Market is expected to reach US$ 1,696.3 million by 2027, as there is rising focus towards legalization for cannabis for medicinal and adult recreational activities.

    The potency test type segment is expected to witness a considerable growth over the next eight years as countries require testing and labeling of cannabis for potency on the basis of THC, CBD, and CBN.

    Mexico cannabis testing market is projected to witness the highest CAGR of 17.7% over the forecast period due to partial legalization of cannabis use in the country. Proposals are being made to the government to fully legalize use of cannabis for both adult recreational and medical cannabis.

    Market Segmentation

    By Test Type


    Heavy Metal

    Terpene Profiling

    Microbial Analysis

    Pesticide Screening

    Residual Solvent Screening


    By Geography

    North America




    Rest of North America

    Contact us:

    Shreyas Tanna

    Phone: +91-740-024-2424

    Absolute Markets Insights